//
Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines
The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study